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Abstract.  The selectins (lectin-EGF-complement 
binding-cell adhesion molecules [LEC-CAMs]) are a 
family of mammalian receptors implicated in the ini- 
tial interactions between leukocytes and vascular en- 
dothelia, leading to lymphocyte homing, platelet bind- 
ing, and neutrophil extravasation. The three known 
selectins, L-selectin (leukocyte adhesion molecule-1 
[LECAM-1]), E-selectin (endothelial-leukocyte adhe- 
sion molecule-1 [ELAM-1]), and P-selectin (GMP-140) 
share structural features that include a calcium-depen- 
dent lectin domain. The sialyl Lewis  x carbohydrate 
epitope has been reported as a ligand for both E- and 
P-selectins. Although L-selectin has been demonstrated 
to bind to carbohydrates, structural features of poten- 
tial mammalian carbohydrate ligand(s) have not been 
well defined. Using an ELISA developed with a sialyl 
Lewisx-containing glycolipid and an E-selectin-IgG 
chimera, we have demonstrated the direct binding of 
the L-selectin-IgG chimera to sialyl Lewis  x. This rec- 
ognition was calcium dependent, and could be blocked 
by Mel-14 antibody but not by other antibodies. Rec- 
ognition was confirmed by the ability of cells express- 
ing the native L-selectin to adhere to immobilized 
sialyl Lewis  x. These data suggest that the sialyl Lewis  x 
oligosaccharide may form the basis of a recognition 
domain common to all three selectins. 
large body of data implicates  a family of receptors, 
the selectins  (lectin-EGF-complement binding-cell 
adhesion molecules [LEC-CAMs]) 1,  in the initial 
interactions between leukocytes and vascular endothelia lead- 
ing to lymphocyte homing, platelet binding, and neutrophil 
extravasation (Hallman et al., 1991; Lawrence and Springer, 
1991; Luscinskas et al., 1989; Watson et al., 1991). L-selec- 
tin is involved in lymphocyte homing to peripheral lymph 
nodes. P-selectin participates in adhesion of activated plate- 
lets. E-selectin seems to facilitate T-cell infiltration at sites 
of cutaneous inflammation (Picker et al.,  1991; Shimizu et 
al., 1991). All three may be involved in neutrophil extravasa- 
tion at sites of tissue damage or infection (Stoolman, 1989). 
The cell surface expression of these three receptors is differ- 
entially regulated, and binding of  one receptor may have sig- 
nificant effects on the expression of  other selectins and on in- 
tegrin adhesion receptors (Kuijpers et al.,  1991; Lo et al., 
1991; Spertiai et al.,  1991). 
The three known selectins, L-Selectin (leukocyte  adhesion 
molecule-1  [LECAM-1],  LAM-1,  gp90MEL),  E-Selectin 
(LECAM-2,  endothelial-leukocyte  adhesion  molecule-1 
1.  Abbn~iations  used in this paper'.  CBP, complement  binding protein; 
ELAM-1,  endothelial-leukocyte  adhesion  molecule-l; HEV,  high  endo- 
thelial venules; ICAM, intercellular adhesion molecule; LECAM-I, leuko- 
cyte adhesion  molecule-I;  LEC-CAM, lectin-EGF-complement  binding- 
cell adhesion molecule. 
[ELAM-1]),  and P-Selectin  (LECAM-3,  GMP-140),  each 
contain a domain with homology to calcium-dependent  lec- 
tins (C-lectins),  an EGF-like domain, and several comple- 
ment binding protein-like (CBP) domains (Bevilacqua et al., 
1989; Johnston et al.,  1989; Lasky et al., 1989; Tedder et 
al., 1989). Identification of the C-lectin domains has led to 
an intense effort to define carbohydrate ligands for these gly- 
coproteins.  There is now general agreement that E-Selectin 
recognizes  NeuNAc  ot2-3 Gal  /31-4 (Fuc  od-3) GlcNAc 
(sialyl-LewisL  or sLe  X) and related oligosaccharides  (Berg 
et al.,  1991; Lowe et al.,  1990; Phillips et al.,  1990; Tie- 
meyer et al., 1991; Tyrrell et al.,  1991; Walz ct al., 1990). 
P-Selectin has been reported to recognize the Lewis  x struc- 
ture (Gal 81-4 (Fuc al-3) GIcNAc) (Larsen et al.,  1990) 
and/or sLe  ~ (Policy et al., 1991); although other ligands are 
possible  (Moore et al.,  1991). 
Although L-selectin is probably the best studied selectin, 
its carbohydrate  ligand has been extremely  difficult to define. 
This is due primarily to the difficulty in obtaining signifi- 
cant quantities of high endothelial venule (HEVs), the tissue 
thought to contain most of  the native ligand. Data suggest the 
L-selectin ligand may contain fucose, sialic acid (Imai et al., 
1991; Stoolman and Rosen, 1983; True et al., 1990), and/or 
mannose (Yednock et al.,  1987) with possible  additional 
anionic character provided by sulfate or phosphate esters. 
Glycoprotein ligands  of L-selectin (Sgl#,  Sgp  ~) recently 
reported from mouse HEVs (Imai et al., 1991) possess many 
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acid,  sulfate),  although neither the structure  of the carbo- 
hydrate chains, nor the exact nature of the residues required 
for recognition  have  been defined as yet.  Here we report 
that L-Selectin,  like E- and P-Selectin, can recognize sLe￿9 
and related oligosaccharides, an observation that now unifies 
the three selectins by ligand as well as protein structure. 
Materials and Methods 
Reagents 
The sLe  x glycolipid,  2-6 sLex glycolipid and the sLex tetrasaccharide (see 
Table I) were synthesized as previously described (Kameyama et al., 1991; 
Tyrrell et al.,  1991). The following materials were obtained from Sigma 
Chemical Co. (St. Louis, MO): bovine brain sulfatides,  GMb GTIb, mixed 
brain gangliusides,  fucoidan, heparin, chondroitin sulfate,  phosphatidyl 
serine,  pbosphatidyl inusitol,  phosphatidyl choline, p-uitrophenylphus- 
phate, mannose l-phosphate, mannose 6-phosphate, galactose  6-phosphate, 
and  glucosamine  2,3  diphosphate.  The  asialo-C-~b  lactusylceramide, 
lacto-N-fucopentaose I  glycolipid,  lacto-N-fucopentaose  H  (Le  a)  glyco- 
lipid, lacto-N-fucopentaose  [] (LeX), and Gb5Cer (GalNAc r  GalNAc 
/~1-3 Gal cd-4 Gal ~1-4 Glc 81- Ceramide) were obtained from Biocarb 
(Lurid,  Sweden).  Sialyllactose  was obtained from Oxford Glycosystems 
(Oxford, England). Mel-14 antibody (Gallatin et al., 1983) was purified by 
ammonium  sulfate  precipitation  from  culture supernatants  (ATCC #HB132  ). 
Anti-ELAM  ant/body  (BBA2  and  anti-interceliuiar adhesion molecule 
(ICAM) antibody 0BBA4) were obtained from British Bio-technology  Ltd. 
Murine IgG was obtained from Zymed Laboratories (South San Francisco, 
CA). 
Selectin-IgG Chimeras 
The production and characterization of L-Selectin-IgG chimera have been 
previously described (Watson et al., 1990). This chimera contains two com- 
plement binding domains, consistent with its natural expression t3Vatson  et 
al.,  1991b). Chimeras for E- and P-Selectins,  containing 2 and 1 comple- 
ment binding protein domains, respectively (see Fig.  1), were constructed 
in a similar manner, expressed  in 293 cells, and purified using a protein A 
affinity column. E- and P-Selectins  were constructed with truncated com- 
plement binding domains to standardize the size of the chimeras and to 
facilitate their secretion. The three chimeras run at the expected  sizes of 
~95 kD (E- and L-Selectins)  and 93 kD (F-Selectin)  on reducing SDS- 
PAGE.  Under  nonreducing  conditions  they  show  apparent  molecular 
masses of 200 kD (E- and L-Selectins)  and 190 kD (F-Selectin)  (data not 
shown), indicating that they are dimers as predicted by the chimera con- 
struction  (see  Fig.  1).  Column  chromatography  of the  three  selectin 
chimeras run in Duibecco's  PBS on Bin-Gel A 0.5 M Gel obtained from 
Bio-Rad l.atboratories  (Richmond, CA) showed similar profiles. Peaks that 
corresponded to expected  molecular sizes of the dimeric chimeras and to 
aggregates  of two or three chimeras were identified  in all three selectins 
(data not shown) suggesting that what aggregation occurred was consistent 
among them.  ELISA  assays  utilizing a  mouse monoclonal anti-human 
IgG, or antibodies specific for L-Selectin (Mel-14), E-Selectin (BBA-2), or 
P-Selectin  (AC1.2) were used to ensure that the proper chimera construct 
was expressed.  We have previously demonstrated that the L-Selactin chi- 
Table I. Nomenclature 
mera was able to block lymphocyte binding to frozen sections of peripheral 
lymph node high endothelial venuies in the Stamper-Woodruff assay (Wat- 
son ct al., 1990). Functional activity of the E- and P-Selecfin IgG chimeras 
was  demonstrated  by  inhibition of  human  umbilical  vein  endothelial 
celi/neutrophil  adhesion (Bevilacqua et al., 1987) and platelet/HL-60 bind- 
ing (Larsen et al., 1990), respectively  (see Fig. 2). The single modification 
in each of these published assays was the incubation of the neutrophlls or 
HL-60 cells with 10 mg/ml human IgG (4~  1 h) before the experiment 
to block potential interaction of the Fc receptors on these cells with the IgG 
portion of the chimeras. 
ELISA Assays 
Glycolipids dissolved in chloroform/methanol/water  (4:8:3) were dried and 
reconstituted in 50% methanol at desired concentrations. 50 ~tl was added 
to each Pro-Bind micmtiter  well (Falcon) and allowed to air dry. Adsorption 
of sLex and 2-6 aLe  x glycolipids  have been quantitated as previously  de- 
scribed (Tyrrell et al., 1991) and found to be equivalent.  Others (Blackburn 
et al., 1986) have qnantitated adsorption etiiciencies  for a variety of addi- 
tional sialic acid-containing  glycolipids and found them to be nearly identi- 
cal. Coated wells were washed twice with distilled water, then blocked with 
5% BSA in Dulbecco's  PBS contaiuing 1 mM Ca  ++ but no big++ for 1 h 
at room temperature. Plates were then washed three times with PBS before 
incubation. The following  were added to PBS containing 1% BSA:  (a) 
1:1,000 dilution of biotinylated goat F(ab') anti-human IgG Fc (Caltng, 
South San Francisco, CA); (b)  1:1,000 dilution of alkaline phosphatase- 
streptavidin (Caltng); and (c) 1/zg/ml L-Selectin, E-Selectin, P-Selectin or 
CD4 IgG chimera. These reagents  were allowed  to form a  complex for 
15-30 rain at room temperature before addition to coated wells (50 ~d/well). 
Inbibitors or antibodies, when used, were added to the selectin complexes 
30 min before transfer of the mixtures to the coated microtiter wells.  The 
seleet.in complexes were incubated on the glycolipid coated surfaces at 37~ 
for 45 min, and then washed three times with PBS followed by three washes 
with distilled water. 50 ~d/well ofp-uitrophenylphosphate  (1 mg/ml  ) in 1 M 
diethanolamine with 0.01% MgCI2, pH 9.8, was ~dd_,~l and the color de- 
veloped in the dark for 30-60 min. Plates were read at 405 nm in a microti- 
ter plate reader (Molecular Devices Corporation, Menlo Park, CA). 
Cell  Adhesion Assays 
EL-4 cells (ATCC #TIB39) were grown in suspension culture in DME 
(Gibco Laboratories, Grand Island, NY) with 10%  FCS,  I% glutamine 
with 50 ~g/ml Gentamycin sulfate  (Gibco Laboratories). These cells ex- 
pressed significant  levels of L-Selectin on their surfaces,  as detected by 
flu~nce  microscopy or FACS analysis using the Mel-14 antibody as the 
primary detection reagent (data not shown).  The cells were harvested by 
centrifugation and washed  in PBS (calcium and mam~esium free),  and 
resnspended in DME with 25 mM Hepes and 10 mg/ml BSA. Glycolipids 
were adsorbed on PVC microtiter wells as described for the ELISA assay 
above. Cells (150,000 per well) were applied  to the wells  by centrifugatiou 
at 50 g for 1 min, then incubated for 1 h at 37~  Wells were immersed 
in DME with 25 mM Hepes,  sealed,  inverted, and centrifuged to apply a 
50-g detachment force for 10 mill. Adherent cells were qnantitated by lac- 
tate dehydrogenase  activity (Brandley et al.,  1987). 
Results 
Characterization of  Selectin-IgG Chimeras 
The inclusion of the hinge region of the IgG Fc portion of 
Name  Structure 
sLe￿9 glycolipid 
2-6 sLe  ~ glycolipid 
sLe￿9 tetra 
2-6 sLe  ~ tetra 
sLeX(Glc) tetra 
PPME 
Fucoidan 
sg: 
NeuNAc  r  Gal 81-4 (Fuc r  GIcNAc ~I-3 Gal 81-4 Glc -  ceramide 
NeuNAc  r  Gal 81-4 (Fuc r  GIcNAc  81-3 Gal 81-4 Glc -  ceramide 
NeuNAc  c~2-3  Gal ~I-4 (Fuc r  GIcNAc 
NeuNAc  ,~2-6  Gal 81-4 (Fuc r  GIcNAc 
NeuNAc  r  Gal ~I-4 (Fuc r  Glc 
polysaccharide containing  mannose 6-phosphate 
polysaccharide containing  fucose  4-sulfate 
glycoprotein  ligand  from mouse HEV  containing  fucose,  sialic  acid,  and sulfate 
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Figure 1. Selectin-immunoglobulin constant region chimeras were 
constructed containing the lectin,  EGF-like (EGF) and comple- 
ment binding protein-like (CBP) domains as previously described 
(Watson et al.,  1990). The L- and E-selectin chimeras contained 
two copies of the CBP domain (truncated at amino acid residues 
332 and 287, respectively), while the P-selectin chimera contained 
one copy of  the CBP domain (truncated at amino acid residue 272). 
All three chimeras contained human IgG 1 from amino acid residue 
234,  which  includes the hinge,  CH2 and  CH3  domains  ("lgG 
Tails"). As illustrated, the hinge region allows for the formation of 
a dimeric sel~'tin-IgG chimera. The CD4 IgG control chimera (not 
shown) has been previously described (Capon et al.,  1989). 
the chimeras used in this study produced a  divalent, anti- 
body-like construct (Fig.  1).  SDS-PAGE of the  chimeras 
revealed the  expected apparent molecular weights  of the 
monomers (reducing gels) and the dimeric construction un- 
der nonreducing conditions (data not shown). Aggregate for- 
marion was  consistent among  all  three Selectin-IgG chi- 
meras. The integrity of the chimeras was demonstrated by 
recognition of both components by appropriate antibodies 
and by biological assay. Anti-human IgG antibody captured 
all three selectin chimeras as well as human IgG, whereas 
only the specific selectins were recognized by antibodies 
directed to  the  lectin  domain  of the  chimeras  (data  not 
shown). L-Selectin-IgG previously had been shown to stain 
HEVs, and block lymphocyte binding to HEVs (Watson et 
al.,  1990).  E-Selectin-IgG inhibited neutrophil binding to 
activated human umbilical vein endothelial cells (Fig. 2 A) 
and  P-Selectin-IgG  inhibited  HL-60  platelet  interaction 
(Fig. 2 B). 
Validation of  ELISA Assays Using E- and 
P-Selectin-lgG Chimeras 
Knowledge of  carbohydrate  ligands recognized  by E-Setectin 
allowed the development of conditions for direct binding 
ELISA  assays  using  the  E-Selectin-IgG chimera  and  the 
sLe  ~ ligand. The E-Selectin chimera bound to an adsorbed 
glycolipid  containing  the  sialyl-Lewis  x  oligosaccharide, 
NeuNAc 2-3  Gal  1-4 (Fuc  I-3) GIcNAc  1-3 Gal  1-4 Glc- 
Ceramide (sLe* glycolipid) (Fig. 3), a known ligand for this 
receptor (Tyrrell et al., 1991). This binding was concentra- 
tion dependent with respect to the adsorbed glycolipid (Fig. 
3)  and  the amount of E-Selectin chimera used  (data  not 
shown). A glycolipid similar to sLe  ￿9 glycolipid but with the 
NeuNAc linked 2-6  instead  of 2-3  (2-6  sLe  ￿9 glycolipid), 
previously shown not to be recognized  by E-Selectin (Tyrrell 
et al.,  1991),  was  used as a  negative control. Binding of 
E-Selectin to  sLe  x glycolipid in this  ELISA was  calcium 
dependent,  and  could  be  blocked  by  antibodies  against 
E-Selectin (but  not control antibodies)  as  well as  by the 
sLe  ~ tetrasaccharide (Table ID (Tyrrell et al.,  1991).  Since 
the detection system in the ELISA was based on the human 
IgG Fc region common to all of the selectin chimeras, this 
assay was extended for use with the P-Selectin IgG chimera. 
P-Selectin also bound to sLe  ￿9 glycolipid in a  dose-depen- 
dent fashion (Fig. 3), although there was more variability in 
level of binding between experiments than seen for either 
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Figure 2.  (a)  E-selectin-IgG 
inhibited neutrophil binding to 
activated HUVEC. HUVECs 
were stimulated with 10 ng/ml 
TNF as previously described. 
Neutrophils, which had been 
preincubated with human IgG 
(10 mg/ml) to block potential 
interaction with Fc receptors 
on  the  IgG  portion  of  the 
chimera, were tested for their 
ability to bind to the  stimu- 
lated HUVEC in the presence 
of  either  E-selectin-IgG  or 
CD4-IgG  (200  ~,g/ml). (b) 
P-seloctin-IgG  chimera  in- 
hibited the adhesion of HL-60 
cells  and  platelets.  HL-60 
cells were preincnhated with 
human IgG, as described above. The cells were then added to platelets, with or without addition of the P-selectin-IgG chimera, and the 
percentage of HL-60 cells in rosettes was determined. 
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Figure 3. The ability of E-se- 
lectin-IgG,  L-selectin-IgG, 
P-selectin-IgG, or CD4-IgG to 
bind directly to various con- 
centrations  of  immobilized 
sLe  x  was  determined.  2,3 
sLe~  (o)  or  2,6  sLe"  (zx) 
glycolipids were  adsorbed in 
increasing  concentrations  to 
microtiter wells as described 
in  Materials  and  Methods. 
The wells were blocked with 
5 %  BSA.  Then, either E-se- 
lectin-IgG (a), L-selectin-IgG 
(b),  P-selectin-IgG  (c),  or 
CD4-IgG  (d)  1 /zg/ml in the 
detection system (see Materi- 
als and Methods) were incu- 
bated (50 #l/well) at 37~  for 
45 rain. After thorough wash- 
ing,  p-nitrophenylphosphate 
(1 mg/ml) was added and chro- 
magen development was read 
as OD at 405 nm. Results are 
presented as the mean (n =  3) 
+  SEM. 
Table II. Inhibitors of L-selectin and E-selectin Chimera ELISA Assays 
A 
Inhibitor 
E-Selectin  L-Selectin  P-Seleetin 
Conc.  % Bound  SEM (n)  % Bound  SEM (n)  % Bound  SEM 
EDTA 
MeI-14 Ab 
Anti-E Ab 
Anti-P Ab 
B 
PPME 
Mannose 1- 
phosphate 
Mannose 6- 
phosphate 
sLe  ~ tetra 
sLex(Glc) tetra 
2  mM  3.2  0.3 
1 /~g/ml  109.6  2.9 
10/,r  100.0  4.3 
1 /~g/ml  4.3  0.2 
1 ttg/ml  94.1  2.5 
1.9  0.4  9.0  0.3 
52.3  2.2  68.3  2.1 
4.6  0.1  66.7  0.7 
96.2  1.8  85.7  1.5 
91.6  2.1  13  1.2 
200#g/ml  95.7  2.1  (6)  33.4  10.1  (12) 
50 mM  61.1  7.7 (3)  58.4  11.8 (3) 
25 mM  92.1  8.1  (3)  67.1  3.8 (3) 
12 mM  110.8  10.9 (4)  76.5  9.5 (3) 
5  mM  60.7  68.1  5.1  (5) 
50 mM  not done  19.9  2.4 (3) 
25 mM  52.2  7.4 (3)  32.4  6.8 (3) 
12 mM  66.1  7.7 (3)  48.2  5.9 (3) 
5  mM  66.95  10.4 (3)  62.8  5.2 (7) 
5 mM  13.8  4.0 (3)  51.5  10.7 (3) 
2  mM  36.6  5.9 (12)  68.7  10.9 (3) 
1 mM  48.9  3.3  (6)  121.0  34.0 (3) 
2  mM  7.2  0.2 (1)  87.9  5.8 (1) 
0.5 mM  30.6  2.6 (1)  93.8  1.8 (1) 
2,3 sLe" glycolipid was adsorbed to microtiter wells at 25 pmol/well and blocked with 5% BSA in PBS containing 1 mM Ca. (A) EDTA (2 raM) was added to 
E-seleetin-IgG, L-selectin-lgG, or P-selectin-IgG in detection system as described in Materials and Methods. Antibodies to E-seleetin-IgG or P-seleetin-IgG (1 
/~g/ml) or to L-seleetin-IgG (1 or 10 ttg/ml) were ineubeted with each seleetin-IgG chimera for 30 minutes at 37 C. (B) Either E-seleetin-IgG or L-seleetin-IgG 
(1 ttg/ml) in detection system as described in Materials and Methods were added to potential inhibitors to final concentrations listed below, and allowed to react 
for 30 rain at room temperature. (,4 and B) These reactants were added to triplicate wells at 50 #l/well and incubated at 37"C for 45 rain. At~er thorough washing, 
p-nitrophenylphosphate was added, (1 mg/ml),  and binding was measured by means of color formation read as OD at 405 nm. Inhibitors of E-seleetin and 
L-selectin-lgG chimera binding to SLe(x) glycolipid are expressed as percent of maximum binding in the presence of no inhibitor. Maximum binding ranged from 
0.500 to 2.500 OD units. Potential inhibitors found to be inactive include 3-sialyUactose  (5 mM), 6-sialyllactose (5 raM), glucose 6-phosphate (5 raM), galactose 
6-phosphate (5 raM), and glucosamine 2,3 disulfate (5 mM). 
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Figure 4. Binding of L-sel6ctin-IgG to 2,3 sLe' glyeolipid was cal- 
cium dependent.  2,3 sLe  ~ glycolipid was adsorbed to microtiter 
wells as previously described. L-selectin-IgG (1/~g/ml), 1% BSA, 
and  1:1,000 dilutions of biotin-labeled goat F(ab')2 and alkaline 
phosphate-labeled  streptavidin were added to PBS with either no 
divalent cations, 1 mM Mg, 1 mM Ca, 1 mM Ca and 0.5 mM Mg, 
or 2.5 mM EDTA and allowed to react for 30 rain. 50/~1 of each 
solution was added to triplicate wells and incubated at 37~  for 45 
min. Control wells adsorbed with 2,6 sic  ￿9 glycolipid were tested 
with L-selectin plus other reactions in PBS with 1 mM Ca. Binding 
was determined by color development of the substrate, p-nitro- 
phenylphosphate, read as OD at 405 nm. Results are presented as 
the mean  +  SEM. 
E- or L-Selectin. This binding was also calcium-dependent, 
and blocked by the appropriate antibody (Table H). 
Direct Binding of the L-Selectin IgG Chimera 
to SLe  ~ Glycolipid 
Using the ELISA assay characterized above, recognition by 
the L-Selectin IgG chimera of the sLe  ~ glycolipid, but not 
to the  2-6  sLe  ￿9 glycolipid,  could be demonstrated.  This 
binding was concentration dependent with respect to the ad- 
sorbed glycolipid (Fig. 3) and the amount of L-Selectin chi- 
mera used (data not shown). The binding of  L-Selectin to the 
sLe  ~ glycolipid was calcium dependent (Fig. 4), and could 
be blocked by the Mel-14 antibody but not by IgG or control 
antibodies (Table H).  L-Selectin did not bind to 2-6 sLe  ￿9 
glycolipid or many other charged or uncharged glycolipids, 
but did bind to some degree to phosphatidyl serine and sulfa- 
tides (Fig. 5).  However, binding to these additional lipids 
was not calcium dependent (Fig. 5). 
Soluble Inhibitors 
A  variety of carbohydrates previously reported to interact 
with L-Selectin were used as potential soluble inhibitors of 
L-Selectin binding  to  sLe  ~ glycolipid  (Table H).  As  ex- 
pected from previous studies, (Mai et al., 1990; Yednock et 
al.,  1987) PPME, the core phosphomannan polysaccharide 
from Hansenula holstii, was able to inhibit L-Selectin adhe- 
sion in a concentration-dependent manner. PPME had little 
effect on E-Selectin binding to sLe  ~ glycolipid (Table lI). 
The sLe  ~ tetrasaccharide competed for binding with both 
selectins, although it competed more effectively and more 
consistently for binding to E-Selecfin. Notably a  similar 
tetrasaccharide with a  reducing-end glucose instead of an 
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Figure 5. A panel of  charged and uncharged glycolipids were tested 
as possible ligands for L-selectin-IgG. 2,3 sLe  ~ glycolipid and the 
other glycolipids were adsorbed to microtiter wells (100 pmol/well) 
as previously described. One set of  control wells, in which no lipid 
was adsorbed, was tested for nonspecific binding of the reactants. 
L-selectin-IgG, biotin-labeled goat F(ab'h anti-human  IgG (Fc) 
and alkaline phosphatase-labeled streptavidin, as described (Mate- 
rials and Methods), were added to PBS containing 1% BSA and ei- 
ther 1 mM Ca or 2 mM EDTA. Results ate presented as the mean 
(n  =  3)  +  SEM.  Other lipids and glycolipids tested and found 
to be inactive included lacto-N-fucopentaose I glycolipid, lacto- 
N-fucopentaose  II  (Le')  glycolipid,  lacto-N-fucopentaose  HI 
(Le  ~) glycolipid, phosphatidyl inositol,  cholesterol,  and choles- 
terol 3-sulfate. 
N-acetylglucosamine, sLex(Glc), was a potent inhibitor of 
E-Selectin, but had little effect  on L-Selectin. At high concen- 
trations  (>10  raM)  mannose  6-phosphate  substantially 
blocked recognition of sI.~ glycolipid by both L-Selectin 
and E-Selectin while mannose 1-phosphate was less effec- 
five. Other compounds, including fucosyllactose and sialyl- 
lactose,  did  not  inhibit  binding  of any  selectin to  sLe'. 
Fucoidan also had little effect on E-Selectin binding, but ini- 
tially appeared to have variable effects on L-Selecfin, at 
times seeming to stimulate rather than inhibit binding. Wells 
pretreated  with  fucoidan and  washed  before addition  of 
receptor  supported  L-Selectin adhesion,  whether or  not 
sLe  x glycolipid was  present  (data  not  shown).  This  sug- 
gested that the fucoidan adhered to the ProBind wells and 
may have mediated L-Selectin (but not E-Selectin) binding 
on its own. Further investigation showed that the L-Selectin- 
fucoidan interaction was not affected  by the addition of  2 mM 
EDTA, and was only partially reduced in the presence of 
higher EDTA concentrations. Thus the interaction appeared 
to be largely calcium independent. 
Cell Adhesion Assays 
A cell-based adhesion assay was used to help verify the bio- 
logical relevance of the interaction between L-Selectin and 
sLe'.  EL-4 cells expressing high  levels of L-Selectin on 
their surfaces (Nottenburg et al., 1990), were able to adhere 
to sLe" glycolipid in a calcium-dependent manner (Fig. 6); 
this adhesion was blocked by the Mel-14 antibody but not by 
control antibody.  These data demonstrate that the native 
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Figure 6. Binding of EL-4 cells, which express L-selectin on their 
cell surfaces, to immobilized 2,3 sLe  ￿9 (a) was inhibited by Mel 14 
Ab and (b) was calcium dependent. Microtiter wells ware adsorbed 
with 2,3 or 2,6 sLe  ￿9 glycolipid, as described previously (Materials 
and Methods). EL-4 cells were harvested and washed in PBS with 
no Ca or Mg, and suspended in DME with 25 mM Hepes and l0 
mg/ml BSA. (a) Antibodies were added to final concentration of 
l0 #g/ml and incubated at room temperature for 30 min. Cells were 
applied to the wells by centrifugation at 50 g for 1 rain and then 
incubated at 25~  for 1 h. Wells were immersed in DME with 25 
mM Hepes, sealed, inverted, and centrifuged at 50 g for l0 rain 
to remove  unbound cells. (b) In a second experiment, the cells were 
prepared as above and 5 mM EDTA was added to washed, resus- 
pended cells which were applied to triplicate wells. Control cells 
without EDTA were applied to triplicate wells coated with either 
2,3- or 2,6 sLe  x. The assay was continued as described above. Re- 
sults are presented as the mean (n  =  3)  +  SEM. 
L-Selectin,  inserted  in  a  cell  membrane,  can  recognize 
sLe  ~, and supports the view that binding seen with the ge- 
neticaily engineered L-Selectin-IgG is not an artifact due to 
the chimera construction. 
Discussion 
This  report  provides  evidence  indicating  that  sLe  ~ and 
related oligosaccharides are recognized by all three known 
selectins.  This  is  an  interesting  finding,  considering that 
these proteins have very similar structural motifs, possess a 
high degree of sequence homology (particularly in the lectin 
domain), and have genes that reside on the same region of 
the  same  chromosome (Collins  et al.,  1991;  Ord et al., 
1990). A considerable amount of attention has been focused 
on defining carbohydrate ligands which interact with the lec- 
tin domains of the three selectins (Brandiey et al.,  1990). 
E-Selectin recognizes NeuNAc ot2-3  Gal 31-4  (Fuc cd-3) 
GlcNAc (sLe  x) and related oligosaccharides (Berg et al., 
1991a; Lowe et al., 1990; Phillips et al., 1990; Tiemeyer et 
al.,  1991;  TyrreU et al.,  1991;  Walz et al.,  1990).  There 
is still a debate concerning the carbohydrate ligand(s) for 
P-Selectin, but  sLe~ is  again  one of the proposed active 
structures (Polley et al.,  1991).  The data suggest that sLe  x 
may form a  core recognition sequence for this  family of 
reA~eptors. 
The L-Selectin IgG chimera used in these ELISA assays 
consists of the lectin, EGF, and the two CBP domains of 
L-Selectin, attached to the Fc portion of human IgG. In this 
case, the natural L-Selectin was truncated at the transmem- 
brane region leaving the extracellular domains of the protein 
intact.  The E-Selectin chimera was  constructed with two 
CBP domains to allow direct comparison with the L-Selectin 
chimera used  in this  study.  Our observation that trunca- 
tion of the CBP domains did not appear to alter binding by 
E-Selectin is in accord with that of Pigott et al. (1991). The 
P-Selectin chimera contained one less CBP domain, an al- 
teration required for expression and secretion of this selec- 
tin. Previously, the L-Selectin IgG chimera has been shown 
to bind to peripheral node high endothelial venules, block 
L-Selectin-mediated lymphocyte adhesion,  and recognize 
PPME and Sgp  ~  in a calcium-dependent manner (Watson 
et al.,  1990; Imai et al.,  1991).  We have shown here that 
L-Selectin IgG chimera recognized the sLe  x oligosaccharide 
epitope (Figs.  3 and 5).  The divalent form of the selectin 
chimeras, when preincubated with the biotinylated anti-IgG 
antibody and the streptavidin-alkaline phosphatase, presum- 
ably form a multivalent complex. Generation of  this multiva- 
lent  complex  appears  to  increase  the  sensitivity  of this 
ELISA. While the absolute levels of binding may be affected 
by the complex formation, relative binding of any selectin- 
chimera complex to various glycolipids can be compared. 
Specificity of sLe  x binding was  indicated by the fact that 
recognition was concentration dependent, calcium sensitive, 
and  blocked  by  the  appropriate  antibody.  Carbohydrate 
specificity was  strongly supported by the  inability of the 
selectin to recognize an otherwise identical glycolipid with 
only a different sialic acid linkage (2-6 sl_~ glycolipid). In 
addition, a wide variety of  other glycolipids and oligosaccha- 
rides, both charged and uncharged, were unable to support 
L-Selectin recognition (Fig. 5, Table II). A cell adhesion as- 
say was used to confirm the interactin of sl_~ with L-Selec- 
tin. EL-4 cells, known to possess significant levels of L-Selec- 
tin and to adhere to HEV sections in the Stamper-Woodruff 
assay (Nottenburg et al., 1990), also adhered to sLe" glyco- 
lipid but not 2-6 sLe  x glycolipid. This adhesion was cal- 
cium dependent and  inhibitable by  the  Mel-14 antibody. 
These data indicated that the native L-Selectin, in situ, will 
also recognize sLe  ~. 
Until  recently,  data  concerning  potential  carbohydrate 
ligands for L-Selectin was mostly indirect, obtained using 
inhibition assays with high concentrations of simple sugars 
(Stoolman and Rosen, 1983), or direct binding assays to non- 
mammalian (yeast, algal) polysaccharides (Imai et al., 1990; 
Yednock et al.,  1987).  Potential glycoprotein ligands  for 
L-Selectin have now been isolated from lymphoid tissue (ad- 
dressins, SgiP~  Berg et al., 1991a; Imai et al., 1991) which 
have the expected characteristics for an L-Selectin ligand, in- 
cluding the presence of sialic acid and fucose. Binding of 
these glycoproteins by L-Selectin is calcium dependent and 
inhibitable by PPME and appropriate antibodies. However, 
only extremely small quantities of these ligands have been 
available and this has delayed completion of the structural 
analysis of their carbohydrate chains. While the presence of 
sLe  ~ or close structural variants has not been demonstrated 
on these native ligands nor on high endothelial venules (Berg 
et al.,  1991b),  we present data here clearly demonstrating 
that  L-Selectin can  recognize sLe  ~.  The binding  of sLe" 
glycolipid by L-Selectin has many of the characteristics pre- 
viously reported for L-Selectin activity (Imai et al.,  1990; 
The Journal of Cell Biology, Volume 117, 1992  900 Yednock et al., 1987).  The sLe  ￿9 glycolipid contains fucose 
and sialic acid, residues implicated in L-Selectin recogni- 
tion. The binding of L-Selectin to sLe  x glycolipid was cal- 
cium  dependent  and  blocked  by  MEL  14  antibody and 
PPME.  At high concentrations, mannose 6-phosphate in- 
hibited E-  and L-Selectin recognition of sLe  ￿9 glycolipid, 
wMle  mannose  1-phosphate  was  less  effective.  Fucoidan 
and sulfatides were recognized by L-Selectin, but not by 
E-Selectin. However,  there were some differences between 
the L-Selectin IgG chimera binding to sLe' glycolipid and 
previously reported L-Selectin activities. In this ELISA as- 
say, recognition of sulfafides and fucoidan was mostly cal- 
cium independent. Although these fucoidan results may seem 
to be in conflict with the recent observations of Kansas et al. 
(1991),  calcium-independent adhesion of lymphocytes to 
fucoidan has been described previously 03randley et al., 
1987).  We are unable to resolve this one difference at this 
time. 
While it is apparent that all three selectins will bind to 
sLe' glycolipid, data obtained using soluble inhibitors (Ta- 
ble II) indicate that there are significant differences among 
the receptors.  The PPME interacts only with L-Selectin, 
while sLe~(Glc) blocks only E-Selectin. The sLe  ￿9 tetrasac- 
charide is most effective at inhibition of E-Selectin binding, 
but does inhibit L-Selectin binding to a lesser extent. While 
certainly not definitive, these data suggest that each selectin 
may require modifications on the basic sLe  ￿9 recognition se- 
quence for optimal affinity. The effects of modifications of 
sLe  ~ on recognition by the three selectins warrants further 
study. 
If a single ligand can be recognized by all three selectins, 
how can one account for the fact that these receptors mediate 
physiologically relevant leukocyte adhesion under different 
functional conditions? Certainly differential regulation of  the 
cell surface expression of the receptors and/or ligands could 
account for the specificity. In addition, at least three other 
hypotheses could explain selectin specificity. (a) Modifica- 
tions (sulfation, acetylation, etc) of the basic sLe  ￿9 oligosac- 
charide structure could result in increased affinity for one 
selectin. (b) The scaffolding to which the oligosaccharide is 
attached (protein or lipid aglycone), or the oligosaccharide 
arrangement on the aglycone may be important to differenti- 
ate recognition among the selectins. (c) A second site on the 
selectins may participate in recognition of the ligand and 
may, at least in part, regulate specificity. Data obtained using 
the soluble inhibitors PPME, sLe  x, and sLex(Glc) suggest 
that there are differences in L-Selectin and E-Selectin bind- 
ing to sLe  ' glycolipid. It is very likely, then, that the sLe  ~ 
epitope (or structural analogue such as sLe') forms the ba- 
sis of a recognition domain that can be further modified. The 
sLe  x epitope may provide a central theme, with each selec- 
tin preferring a variation on that theme. 
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